Expert recommendations for the diagnosis and treatment of iron-deficiency anemia during pregnancy and the postpartum period in the Asia-Pacific region.
Anemia during pregnancy and the postpartum period is commonly caused by iron deficiency and is a significant worldwide issue with severe consequences for both mother and developing fetus. From a worldwide perspective, iron-deficiency anemia (IDA) during pregnancy is highest in the Asia-Pacific region; however, there has been little guidance in this region for safe and effective treatment. An expert panel was convened to develop a concise and informative set of recommendations for the treatment of IDA in pregnant and postpartum women in the Asia-Pacific region. This manuscript provides these recommendations and aims to reduce the morbidity and mortality associated with IDA in pregnant and postpartum women in the Asia-Pacific region. The consensus recommendations define anemia as a hemoglobin (Hb) level <10.5 g/dL during pregnancy and <10 g/dL during the postpartum period, and provide cut-off Hb levels to initiate therapy with oral iron, intravenous iron or red blood cell transfusion.
Feto-maternal Hematology Unit, University Hospital, Zurich, Switzerland. christian.breymann@usz.ch
Christian
C
Breymann
Xu-Ming
XM
Bian
Lourdes R
LR
Blanco-Capito
Christopher
C
Chong
Ghazala
G
Mahmud
Rakhshanda
R
Rehman
D018798:Anemia, Iron-Deficiency / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D001208:Asia; D017707:Erythrocyte Transfusion; D005260:Female; D006801:Humans; D007501:Iron / Q000008:administration & dosage; D010139:Pacific Islands; D049590:Postpartum Period; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000175:diagnosis* / Q000628:therapy*
D007501:Iron